Basic Information
Basic information for SOX9-AS1-239-25aa
Peptide Name SOX9-AS1-239-25aa
Genome Position chr17:72075867-72075941[-]
Species Human
Peptide Sequence MRAVIITIPGNSQRKRKGKRFGQDS
Peptide Length 25
Unique No (SOX9-AS1-204-25aa-2,SOX9-AS1-213-25aa,SOX9-AS1-220-25aa-1,SOX9-AS1-223-25aa,SOX9-AS1-225-25aa-1,SOX9-AS1-228-25aa-2,SOX9-AS1-229-25aa-2,SOX9-AS1-231-25aa-1,SOX9-AS1-232-25aa,SOX9-AS1-234-25aa-1,SOX9-AS1-237-25aa)
Grand Average of Hydropathicity -0.984
Relative Molecular Mass 3276.72
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000234899;SOX9-AS1
Transcript ID/Name ENST00000671151;SOX9-AS1-239
Transcript Length 1258
Coding Ability 0.6407
DNA Sequence Corresponding to Peptide ATGAGAGCAGTAATCATCACGATCCCAGGGAACAGCCAAAGGAAGAGAAAAGGCAAAAGATTTGGACAAGACTCA
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :